Lab Services

Precision and Innovation with comprehensive Lab services.

Labs

At Lambda Therapeutic Research, we drive drug development to new heights with our state-of-the-art Lab Services, encompassing critical domains such as bioanalytical, biosimilars, and central clinical lab. Our services combine top-notch scientific knowledge with cutting-edge tech, ensuring precise and high-quality results. We know the importance of timely, accurate, and reliable data for successful drug development. 

Lambda Therapeutic Research stands as a beacon of collaboration, serving as your end-to-end partner for all your lab service requirements. Our global reach and expertise in diverse therapeutic areas set us apart, empowering your quest for innovative solutions and breakthroughs. Recently, Lambda proudly received the ‘Industry Partner of the Year‘ Award at the Global Generics & Biosimilar Awards 2023. Discover the Lambda Advantage today, where precision meets progress and innovation fuels excellence in clinical development.

Bioanalytical Lab

Lambda Therapeutic Research offers a comprehensive suite of bioanalytical capabilities specializing in cell-based assays, biomarkers, immunogenicity, and pharmacokinetics (PK). With state-of-the-art facilities and a team of experienced scientists, Lambda provides end-to-end solutions for the analysis of small molecules, biomarkers, biologics, and therapeutic elemental drugs. Our team has extensive experience in developing validated and qualified methods for generic and NCE molecules, including ultra-trace detection, endogenous, and chiral assays.

Bioanalytical Methods Assay List:

Access our latest assay list showcasing our extensive Bioanalytical Assay capabilities, boasting over 1400 validated methods. Our Bioanalytical Labs in India and Canada have successfully conducted diverse Bioanalytical Assays across a wide range of biological matrices. The assay list is categorized as follows:

Recently Validated Methods

Premium Methods

Large Molecules / Therapeutic Proteins / Biosimilars

Immunogenicity Assessment

Small Molecules

New Chemical Entities

In-Vitro Studies

PD Markers

Healthcare Hygiene Products

India

Canada

Small Molecule Experience

Biosimilars & Large Molecule Bioanalysis

Full-Spectrum Offerings

Pharmacokinetic Assessment

Immunogenicity Assessment

PD/Biomarker Evaluation

Toxicokinetic Measurement

Method Development & Validation

Quick turnaround Bioanalysis

The Lambda Advantage

Bioanalytical Expertise
  • PK assays
  • Immunogenicity assays (ADA)
  • Neutralizing Antibody (NAb) Assays 
  • Pharmacodynamic (PD) Biomarker Assays
Analytical Platforms
  • Enzyme-Linked Immunosorbent Assays (ELISA)
  • Electrochemiluminescent Assays (ECLIA)
  • In-vitro diagnostics (for Biomarkers)
  • MSD Reader
  • Cell Based Assays (for NAb)
  • Flow Cytometry
Value Additions
  • Antibody sourcing & Antigen Affinity-based purification.
  • Conjugations: Biotin, Digoxigenin, HRP, Ruthenium

Extensive Experience

Adalimumab

Bevacizumab

Denosumab

Filgrastim

Vedolizumab

GCSF & PEG G-CSF​

Glucagon

Pegfilgrastim

Pertuzumab

Ranibizumab

Rituximab

rHu-FSH